Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
BioStem Technologies, Inc. (BSEM) had Normalized Income after Taxes of $47.48M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$47.48M |
|
$-6.58M |
|
-- |
|
$47.48M |
|
-- |
|
$47.48M |
|
-- |
|
$47.48M |
|
$47.48M |
|
$47.48M |
|
$3.08M |
|
$3.08M |
|
|
Normalized Income after Taxes |
$47.48M |
$47.48M |
|
$47.48M |
|
16.73M |
|
16.73M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
-13.86% |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|